Gapping down
In reaction to earnings/guidance:
- MEI -9.9%, ESTC -8.7%, VEEV -7%, DG -3.5%, SMTC -1.9%
Other news:
- KPLT -12.6% (provides inter update on quarter-to-date gross orginiations)
- VBIV -6.1% (to present new survival data from Phase 2a Study)
- MEIP -3.8% (prices offering of 17.5 mln shares of common stock at $2.60 per share)
- WE -3.1% (discloses material weakness in internal control over financial reporting to amend financial statements; issues Statement Regarding 8-K Filing on Former SPAC's Financial Statements)
- IPHA -2.6% (to Present Monalizumab Data at ESMO Immuno-Oncology 2021 Congress)
- COST -2% (reports Nov adjusted comps of +9.2%)
Analyst comments:
- BYSI -7.5% (downgraded to Hold from Buy at Jefferies; downgraded to Underperform from Buy at BofA Securities)
- EXPD -2.3% (downgraded to Underweight from Equal-Weight at Morgan Stanley)